Copyright
©The Author(s) 2022.
World J Diabetes. Jul 15, 2022; 13(7): 553-565
Published online Jul 15, 2022. doi: 10.4239/wjd.v13.i7.553
Published online Jul 15, 2022. doi: 10.4239/wjd.v13.i7.553
Parameter | Women with TBS > 1.31 (n = 53) | Women with TBS ≤ 1.31 (n = 43) | P value |
Age (yr) | 62 (59; 68) | 65 (59; 72) | 0.09 |
Age at menopause (yr) | 50 (46; 53) | 50 (45; 52.5) | 0.6 |
Time since menopause (yr) | 14 (10; 19) | 17 (9; 21.5) | 0.72 |
Diabetes duration (yr) | 14 (10; 20) | 19 (12; 23) | 0.052 |
Height (cm) | 160 (156; 165) | 164 (160; 167) | 0.008 |
Body weight (kg) | 90 (81; 101) | 84 (80; 93) | 0.2 |
BMI (kg/m2) | 35.3 (32.5; 37.2) | 32 (29.7; 34.9) | 0.007 |
WHR | 0.95 (0.93; 1.0) | 1.02 (0.9; 1.05) | 0.37 |
HbA1c (%) | 8.5 (7.1; 9.3) | 8.9 (7.7; 10.1) | 0.13 |
Total cholesterol (mmol/L) | 4.4 (4.1; 5.6) | 5.1 (3.9; 5.7) | 0.44 |
LDL-cholesterol (mmol/L) | 2.9 (2.6; 3.7) | 3.4 (2.7; 3.9) | 0.21 |
HDL-cholesterol (mmol/L) | 1.3 (1.1; 1.5) | 1.2 (1.1; 1.5) | 0.67 |
Triglycerides (mmol/L) | 1.8 (1.1; 2.5) | 2.1 (1.4; 2.7) | 0.31 |
hsCRP (mmol/L) | 3.1 (1.8; 8.3) | 3.3 (1.5; 7.3) | 0.71 |
Calcium (mmol/L) | 2.4 (2.4; 2.5) | 2.4 (2.4; 2.5) | 0.96 |
Phosphorus (mmol/L) | 1.2 (1.1; 1.4) | 1.3 (1.2; 1.4) | 0.11 |
Alkaline phosphatase (IU/L) | 84.6 (67.3; 107.3) | 81.1 (64.8; 98.5) | 0.66 |
PTH (pg/mL) | 32.4 (24; 45.4) | 31.2 (15.3; 39.0) | 0.36 |
25(OH)D (ng/mL) | 21.3 (15.8; 26.5) | 18.7 (12.4; 24.2) | 0.07 |
eGFR (mL/min/1.73 m2) | 76 (55; 93) | 72 (57; 92) | 0.7 |
UACR (mg/mmoL) | 0.6 (0.3; 1.1) | 0.5 (0.3; 1.0) | 0.18 |
Diabetic retinopathy, n (%) | 24 (45.3%) | 24 (55.8%) | 0.38 |
CKD, n (%) | 22 (41.5%) | 20 (46.5%) | 0.89 |
Diabetic neuropathy, n (%) | 53 (100%) | 43 (100%) | 0.76 |
Peripheral artery disease, n (%) | 19 (35.8%) | 19 (48.3%) | 0.42 |
Coronary artery disease, n (%) | 17 (32.1%) | 11 (27.6%) | 0.59 |
Metformin, n (%) | 43 (81.1%) | 37 (86%) | 0.68 |
Sulfonylurea, n (%) | 20 (37.7%) | 14 (32.6%) | 0.67 |
DPP4 inhibitor, n (%) | 3 (5.7%) | 6 (14%) | 0.49 |
SGLT2 inhibitor, n (%) | 16 (30.2%) | 10 (23.3%) | 0.56 |
Insulin, n (%) | 38 (71.7%) | 32 (74.4%) | 0.82 |
Fracture in medical history, n (%) | 6 (11.3%) | 14 (32.6%) | 0.02 |
Low-energy fracture in medical history, n (%) | 2 (3.8%) | 9 (20.9%) | 0.01 |
- Citation: Fazullina ON, Korbut AI, Klimontov VV. Factors associated with trabecular bone score in postmenopausal women with type 2 diabetes and normal bone mineral density. World J Diabetes 2022; 13(7): 553-565
- URL: https://www.wjgnet.com/1948-9358/full/v13/i7/553.htm
- DOI: https://dx.doi.org/10.4239/wjd.v13.i7.553